FI943024A0 - Kantasoluja estävät proteiinit - Google Patents
Kantasoluja estävät proteiinitInfo
- Publication number
- FI943024A0 FI943024A0 FI943024A FI943024A FI943024A0 FI 943024 A0 FI943024 A0 FI 943024A0 FI 943024 A FI943024 A FI 943024A FI 943024 A FI943024 A FI 943024A FI 943024 A0 FI943024 A0 FI 943024A0
- Authority
- FI
- Finland
- Prior art keywords
- stem cells
- inhibiting stem
- proteins inhibiting
- proteins
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919127319A GB9127319D0 (en) | 1991-12-23 | 1991-12-23 | Modified proteins |
GB929221587A GB9221587D0 (en) | 1992-10-14 | 1992-10-14 | Modified proteins |
PCT/GB1992/002390 WO1993013206A1 (en) | 1991-12-23 | 1992-12-23 | Stem cell inhibiting proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
FI943024A0 true FI943024A0 (fi) | 1994-06-22 |
FI943024A FI943024A (fi) | 1994-06-22 |
Family
ID=26300071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI943024A FI943024A (fi) | 1991-12-23 | 1994-06-22 | Kantasoluja estävät proteiinit |
Country Status (10)
Country | Link |
---|---|
US (2) | US6057123A (fi) |
EP (1) | EP0627003A1 (fi) |
JP (1) | JPH07502404A (fi) |
AU (1) | AU679436B2 (fi) |
CA (1) | CA2125985C (fi) |
FI (1) | FI943024A (fi) |
HU (2) | HUT69788A (fi) |
NO (1) | NO942380L (fi) |
NZ (1) | NZ246354A (fi) |
WO (1) | WO1993013206A1 (fi) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9308060D0 (en) * | 1993-04-19 | 1993-06-02 | Cancer Res Campaign Tech | Stem cell inhibitor |
GB9312344D0 (en) * | 1993-06-15 | 1993-07-28 | British Bio Technology | Pharmaceutical formulations |
US5728377A (en) * | 1993-07-20 | 1998-03-17 | Board Of Regents, The University Of Texas System | Methods and compositions incorporating IP-10 |
ES2177625T3 (es) * | 1993-12-24 | 2002-12-16 | Wolf-Georg Forssmann | Citoquina cc-1 humana circulante. |
GB9517014D0 (en) * | 1995-08-19 | 1995-10-25 | British Biotech Pharm | Haematopoietic recovery |
US5786335A (en) * | 1995-11-06 | 1998-07-28 | Warner-Lambert Company | Sulfhydryl containing peptides for treating vascular disease |
GB9600559D0 (en) * | 1996-01-11 | 1996-03-13 | British Biotech Pharm | Use of chemokines |
AU4561497A (en) * | 1996-09-25 | 1998-04-17 | British Biotech Pharmaceuticals Limited | Human rantes mutants incapable of aggregate formation |
US6121023A (en) * | 1998-01-22 | 2000-09-19 | Akzo Nobel N.V. | Isothermal transcription based assay for the detection and quantification of the chemokine rantes |
CA2245224A1 (en) | 1998-08-14 | 2000-02-14 | Jiang-Hong Giong | Chemokine receptor antagonists and chemotherapeutics |
CA2305787A1 (en) | 2000-05-09 | 2001-11-09 | The University Of British Columbia | Cxcr4 antagonist treatment of hematopoietic cells |
JP2002506830A (ja) | 1998-03-13 | 2002-03-05 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 治療的ケモカイン受容体アンタゴニスト |
CA2335109A1 (en) * | 2000-04-12 | 2001-10-12 | Chemokine Therapeutics Corporation | Cxcr4 agonist treatment of hematopoietic cells |
US7378098B2 (en) | 2000-04-12 | 2008-05-27 | The University Of British Columbia | CXC chemokine receptor 4 agonist peptides |
US7368425B2 (en) | 2006-03-24 | 2008-05-06 | Chemokine Therapeutics Corp. | Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
US20050059584A1 (en) | 2002-08-16 | 2005-03-17 | Ahmed Merzouk | Novel chemokine mimetics synthesis and their use |
EP1349918B1 (en) * | 2000-12-06 | 2014-08-06 | Anthrogenesis Corporation | Method of collecting placental stem cells |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
CA2856986C (en) | 2001-02-14 | 2019-08-13 | Anthrogenesis Corporation | Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders |
US6515001B2 (en) | 2001-03-05 | 2003-02-04 | Chemokine Therapeutic Corporation | IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
WO2003051921A1 (en) | 2001-12-17 | 2003-06-26 | Applied Research Systems Ars Holding N.V. | Chemokine mutants acting as chemokine antagonists |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
WO2003102151A2 (en) * | 2002-05-30 | 2003-12-11 | Celgene Corporation | Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
JP2004196770A (ja) * | 2002-10-24 | 2004-07-15 | Effector Cell Institute Inc | 樹状細胞前駆体の血中レベル上昇剤 |
CN1717177A (zh) | 2002-11-26 | 2006-01-04 | 人类起源公司 | 细胞治疗剂、细胞治疗单元及其用于治疗的方法 |
US7662781B2 (en) * | 2005-01-31 | 2010-02-16 | Eci, Inc. | Immunopotentiating agent |
PE20070771A1 (es) | 2005-10-13 | 2007-08-11 | Anthrogenesis Corp | Inmunomodulacion mediante el uso de celulas madres de la placenta |
CA2633775A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
EP2471904B1 (en) | 2005-12-29 | 2018-10-24 | Celularity, Inc. | Placental stem cell populations |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
NZ597779A (en) | 2007-02-12 | 2013-07-26 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
SI2203176T1 (sl) | 2007-09-28 | 2015-04-30 | Anthrogenesis Corporation | Tumorska supresija z uporabo humanega perfuzata placente in intermediarnih naravnih celic ubijalk, pridobljenih iz humane placente |
US8828376B2 (en) * | 2008-08-20 | 2014-09-09 | Anthrogenesis Corporation | Treatment of stroke using isolated placental cells |
NZ591292A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
US8728805B2 (en) | 2008-08-22 | 2014-05-20 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
RU2015130665A (ru) | 2008-11-19 | 2018-12-24 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
MX353489B (es) * | 2009-07-02 | 2018-01-16 | Anthrogenesis Corp | Metodo para producir eritrocitos sin celulas alimentadoras. |
WO2011094181A1 (en) | 2010-01-26 | 2011-08-04 | Anthrogenesis Corporation | Treatment of bone-related cancers using placental stem cells |
PT2556145T (pt) | 2010-04-07 | 2016-10-25 | Anthrogenesis Corp | Angiogénese usando células estaminais placentárias |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
JP5996533B2 (ja) | 2010-07-13 | 2016-09-21 | アントフロゲネシス コーポレーション | ナチュラルキラー細胞を生成させる方法 |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
AU2012262273B2 (en) | 2011-06-01 | 2017-09-14 | Celularity Inc. | Treatment of pain using placental stem cells |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
EP2953635A4 (en) | 2013-02-05 | 2016-10-26 | Anthrogenesis Corp | NATURAL KILLER CELLS FROM PLAZENTA |
KR20170123849A (ko) * | 2016-04-29 | 2017-11-09 | 주식회사유한양행 | Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도 |
WO2020014298A1 (en) | 2018-07-10 | 2020-01-16 | Rush University Medical Center | Use of immunomodulators to control infection and stimulate healing in normal and diabetic wounds |
WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929555A (en) * | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
DE69020573T3 (de) * | 1989-09-25 | 1999-12-16 | Genetics Inst | Verfahren zur wachstumshemmung von stammzellen. |
JPH03228683A (ja) * | 1989-12-20 | 1991-10-09 | Chemo Sero Therapeut Res Inst | 生理活性ペプチドLD78α、LD78βおよびその製法、これに用いる組換えプラスミド |
JPH06503710A (ja) * | 1990-09-14 | 1994-04-28 | カイロン コーポレイション | 酵母細胞におけるマクロファージ誘導タンパク質(mip)の発現 |
-
1992
- 1992-12-23 JP JP5511275A patent/JPH07502404A/ja active Pending
- 1992-12-23 CA CA002125985A patent/CA2125985C/en not_active Expired - Fee Related
- 1992-12-23 HU HU9401902A patent/HUT69788A/hu unknown
- 1992-12-23 NZ NZ246354A patent/NZ246354A/en unknown
- 1992-12-23 WO PCT/GB1992/002390 patent/WO1993013206A1/en not_active Application Discontinuation
- 1992-12-23 AU AU32604/93A patent/AU679436B2/en not_active Ceased
- 1992-12-23 US US07/982,759 patent/US6057123A/en not_active Expired - Fee Related
- 1992-12-23 EP EP93901048A patent/EP0627003A1/en not_active Withdrawn
-
1994
- 1994-06-22 FI FI943024A patent/FI943024A/fi unknown
- 1994-06-22 NO NO942380A patent/NO942380L/no not_active Application Discontinuation
-
1995
- 1995-05-26 US US08/450,905 patent/US5856301A/en not_active Expired - Fee Related
- 1995-06-22 HU HU95P/P00383P patent/HU211605A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
NZ246354A (en) | 1995-10-26 |
AU3260493A (en) | 1993-07-28 |
CA2125985A1 (en) | 1993-07-08 |
CA2125985C (en) | 2001-04-17 |
HU9401902D0 (en) | 1994-09-28 |
US6057123A (en) | 2000-05-02 |
AU679436B2 (en) | 1997-07-03 |
FI943024A (fi) | 1994-06-22 |
US5856301A (en) | 1999-01-05 |
EP0627003A1 (en) | 1994-12-07 |
NO942380L (no) | 1994-08-23 |
HUT69788A (en) | 1995-09-28 |
HU211605A9 (en) | 1995-12-28 |
NO942380D0 (fi) | 1994-06-22 |
JPH07502404A (ja) | 1995-03-16 |
WO1993013206A1 (en) | 1993-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI943024A0 (fi) | Kantasoluja estävät proteiinit | |
NO982350D0 (no) | Stamcellefaktor | |
NO920388L (no) | Tilbakeslagsventil | |
DK91192D0 (da) | Protein | |
NO942066D0 (no) | Peptidderivater | |
DK540289D0 (da) | Protein | |
FR2632154B1 (fr) | Moissonneuse | |
DE69415775D1 (de) | Verbesserte Stielzusammensetzung | |
FR2634652B1 (fr) | Valve respiratoire asservissable | |
FI925636A0 (fi) | Katod foer anvaendning i en elektrolytisk cell | |
DK132892D0 (da) | Proteiner | |
BR8907717A (pt) | Valvula | |
MX9206015A (es) | Valvula de retencion | |
DK197989A (da) | Peptidanaloger | |
DE69406926T2 (de) | Cholesterinreduzierte eier | |
DE69209522T2 (de) | Tracheostomventile | |
FI934588A0 (fi) | Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben | |
KR900700503A (ko) | 펩티드 | |
DE59206308D1 (de) | Schaftprothese | |
AT397701B (de) | Vorrangumschaltventil | |
BR9102220A (pt) | Valvula de retencao | |
DK0505600T3 (da) | Ventilindretning | |
DK139193D0 (da) | Rektangulaer aegbakke | |
ITMI920274A1 (it) | Valvola | |
DK120792D0 (da) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Name/ company changed in application |
Owner name: BRITISH BIOTECH PHARMACEUTICALS LIMITED |